Expression profile of mRNAs and miRNAs related to mitogen-activated kinases in HaCaT cell culture treated with lipopolysaccharide a and adalimumab

References

• Cho SH, Kim HS, Lee W, et al. Eckol from ecklonia cava ameliorates TNF-α/IFN-γ-induced inflammatory responses via regulating MAPKs and NF-κB signaling pathway in HaCaT cells. Int Immunopharmacol. 2020;82:106146. doi: 10.1016/j.intimp.2019.106146
   PubMed Web of Science ®Google Scholar
• Yildiz A, Kaya Y, Yildiz A, et al. Post-translational regulation of the activity of ERK/MAPK and PI3K/AKT signaling pathways in neuroblastoma cancer. In: Post-translational modifications in cellular functions and diseases. IntechOpen; 2021. doi: 10.5772/intechopen.96176
   Google Scholar
• Yue J, López JM. Understanding MAPK signaling pathways in apoptosis. Int J Mol Sci. 2020;21(7):2346. doi: 10.3390/ijms21072346
   PubMed Web of Science ®Google Scholar
• Zou J, Lei T, Guo P, et al. Mechanisms shaping the role of ERK1/2 in cellular senescence (review). Mol Med Rep. 2019;19(2):759–770.
   PubMed Web of Science ®Google Scholar
• Pua LJW, Mai CW, Chung FFL, et al. Functional roles of JNK and p38 MAPK signaling in nasopharyngeal carcinoma. Int J Mol Sci. 2022;23(3):1108. doi: 10.3390/ijms23031108
   PubMed Web of Science ®Google Scholar
• Furue K, Ito T, Tanaka Y, et al. The EGFR-ERK/JNK-CCL20 pathway in scratched keratinocytes may underpin koebnerization in psoriasis patients. Int J Mol Sci. 2020;21(2):434. doi: 10.3390/ijms21020434
   PubMed Web of Science ®Google Scholar
• Rendon A, Schäkel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019;20(6):1475. doi: 10.3390/ijms20061475
   PubMed Web of Science ®Google Scholar
• Lories RJU, Derese I, Luyten FP, et al. Activation of nuclear factor kappa B and mitogen activated protein kinases in psoriatic arthritis before and after etanercept treatment. Clin Exp Rheumatol. 2008;26(1):96–102.
   PubMed Web of Science ®Google Scholar
• Baran A, Nowowiejska J, Kamiński TW, et al. Circulating MAdCAM-1 and ITGB7 in patients with plaque psoriasis and eruptive lichen planus—preliminary data. Biol. 2021;10(11):1129. doi: 10.3390/biology10111129
   PubMedGoogle Scholar
• Griffiths CEM, Armstrong AW, Gudjonsson JE, et al. Psoriasis. Lancet Lond Engl. 2021;397(10281):1301–1315. doi: 10.1016/S0140-6736(20)32549-6
   PubMed Web of Science ®Google Scholar
• Foks-Ciekalska A, Jarząb J, Bożek A, et al. The vicious circle effect: stress as effect and cause in patients with psoriasis. Postepy Dermatol Alergol. 2023;40(3):362–367. doi: 10.5114/ada.2022.120452
   PubMed Web of Science ®Google Scholar
• Wang Y, Han D, Huang Y, et al. Oral administration of punicalagin attenuates imiquimod-induced psoriasis by reducing ROS generation and inflammation via MAPK/ERK and NF-κB signaling pathways. Phytother Res. 2024;38(2):713–726. doi: 10.1002/ptr.8071
   PubMed Web of Science ®Google Scholar
• Hervé F, Bakchine H, Le Loc’h H, et al. Hemorrhagic shock syndrome with encephalopathy. Arch Fr Pediatr. 1987;44(3):195–197.
   PubMedGoogle Scholar
• Ganguly P, Macleod T, Wong C, et al. Revisiting p38 Mitogen-Activated Protein Kinases (MAPK) in inflammatory arthritis: A narrative of the emergence of MAPK-Activated Protein kinase inhibitors (MK2i). Pharmaceuticals. 2023;16(9):1286. doi: 10.3390/ph16091286
   Web of Science ®Google Scholar
• Zhu X, Xu Q, Liu Z, et al. Qingre lishi decoction ameliorates imiquimod-induced psoriasis-like skin lesions in SKH-1 mice by regulating the Treg-DC-Th17 axis and inhibiting MAPK-mediated DC maturation. J Ethnopharmacol. 2024;318:116931. doi: 10.1016/j.jep.2023.116931
   PubMed Web of Science ®Google Scholar
• Reich A, Adamski Z, Chodorowska G, et al. Psoriasis. Diagnostic and therapeutic recommendations of the Polish dermatological society. Part 2. Dermatol Rev Dermatol. 2020;107(2):110–137.
   Google Scholar
• Reich A, Adamski Z, Chodorowska G, et al. Psoriasis. Diagnostic and therapeutic recommendations of the Polish dermatological society. Part 1. Dermatol Rev Dermatol. 2020;107(2):92–108.
   Google Scholar
• Xhaja A, Shkodrani E, Frangaj S, et al. An epidemiological study on trigger factors and quality of life in psoriatic patients. Mater Socio Medica. 2014;26(3):168–171. doi: 10.5455/msm.2014.26.168-171
   PubMedGoogle Scholar
• Yu XJ, Li CY, Dai HY, et al. Expression and localization of the activated mitogen-activated protein kinase in lesional psoriatic skin. Exp Mol Pathol. 2007;83(3):413–418. doi: 10.1016/j.yexmp.2007.05.002
   PubMed Web of Science ®Google Scholar
• Guo J, Zhang H, Lin W, et al. Signaling pathways and targeted therapies for psoriasis. Signal Transduct Target Ther. 2023;8(1):1–38. doi: 10.1038/s41392-023-01655-6
   PubMed Web of Science ®Google Scholar
• Lai B, Wu CH, Lai JH. Activation of c-Jun N-Terminal Kinase, a potential therapeutic target in autoimmune arthritis. Cells. 2020;9(11):2466. doi: 10.3390/cells9112466
   PubMed Web of Science ®Google Scholar
• Wu X, Ma Y, Wang L, et al. A route for investigating psoriasis: from the perspective of the pathological mechanisms and therapeutic strategies of cancer. Int J Mol Sci. 2023;24(18):14390. doi: 10.3390/ijms241814390
   PubMed Web of Science ®Google Scholar
• Xu F, Xu J, Xiong X, et al. Salidroside inhibits MAPK, NF-κB, and STAT3 pathways in psoriasis-associated oxidative stress via SIRT1 activation. Redox Rep. 2019;24(1):70–74. doi: 10.1080/13510002.2019.1658377
   PubMedGoogle Scholar
• Conley RR, Kelly DL, Love RC, et al. Rehospitalization risk with second-generation and depot antipsychotics. Ann Clin Psychiatry. 2003;15(1):23–31. doi: 10.3109/10401230309085667
   PubMedGoogle Scholar
• Xu Q, Sheng L, Zhu X, et al. Jingfang granules exert anti-psoriasis effect by targeting MAPK-mediated dendritic cell maturation and PPARγ-mediated keratinocytes cell cycle progression in vitro and in vivo. Phytomed Published online. 2023;117:154925. doi: 10.1016/j.phymed.2023.154925
   PubMed Web of Science ®Google Scholar
• Bai D, Cheng X, Li Q, et al. Eupatilin inhibits keratinocyte proliferation and ameliorates imiquimod-induced psoriasis-like skin lesions in mice via the p38 MAPK/NF-κB signaling pathway. Immunopharmacol Immunotoxicol. 2023;45(2):133–139.
   PubMed Web of Science ®Google Scholar
• Risco A, Cuenda A. New insights into the p38γ and p38δ MAPK pathways. J Signal Transduct. 2012;2012:1–8. [cited 2024 February 1] Available from: https://www.hindawi.com/journals/archive/2012/520289/
   Google Scholar
• Assefi M, Lewandrowski KU, Lorio M, et al. Network-based in silico analysis of new combinations of modern drug targets with methotrexate for response-Based treatment of rheumatoid arthritis. J Pers Med. 2023;13(11):1550. doi: 10.3390/jpm13111550
   PubMed Web of Science ®Google Scholar
• Xiao Y, Wang H, Wang C, et al. miR-203 promotes HaCaT cell overproliferation through targeting LXR-α and PPAR-γ. Cell Cycle. 2020;19(15):1928–1940. doi: 10.1080/15384101.2020.1783934
   PubMed Web of Science ®Google Scholar
• Grabarek BO, Dąbala M, Kasela T, et al. Changes in the expression pattern of DUSP1-7 and miRNA regulating their expression in the keratinocytes treated with LPS and adalimumab. Curr Pharm Biotechnol. 2022;23(6):873–881. doi: 10.2174/1389201022666210802102508
   PubMed Web of Science ®Google Scholar
• Kasela T, Dąbala M, Mistarz M, et al. Effects of cyclosporine a and adalimumab on the expression profiles histaminergic system-associated genes and microRnas regulating these genes in HaCaT cells. Cell Cycle. 2022;0(0):1–18. doi: 10.1080/15384101.2022.2103342
   Google Scholar
• Adwent I, Grabarek BO, Kojs-Mrożkiewicz M, et al. The influence of adalimumab and cyclosporine a on the expression profile of the genes related to TGFβ signaling pathways in keratinocyte cells treated with lipopolysaccharide A. Mediators Inflamm. 2020;2020:3821279. doi: 10.1155/2020/3821279
   PubMed Web of Science ®Google Scholar
• Evaluation of the influence of adalimumab on the expression profile of leptin-related genes and proteins in keratinocytes treated with lipopolysaccharide A - PubMed. [cited 2023 May 19]. Available from. https://pubmed.ncbi.nlm.nih.gov/33562571/
   Google Scholar
• Belinky F, Nativ N, Stelzer G, et al. PathCards: multi-source consolidation of human biological pathways. Database J Biol Databases Curation. 2015;2015:bav006. doi: 10.1093/database/bav006
   PubMedGoogle Scholar
• Agarwal V, Bell GW, Nam JW, et al. Predicting effective microRNA target sites in mammalian mRnas. In: Izaurralde E, editor. eLife. Vol. 4. 2015; p. e05005. doi :10.7554/eLife.05005
   Google Scholar
• Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48(D1):D127–D131. doi: 10.1093/nar/gkz757
   PubMed Web of Science ®Google Scholar
• Liu W, Wang X. Prediction of functional microRNA targets by integrative modeling of microRNA binding and target expression data. Genome Biol. 2019;20(1):18. doi: 10.1186/s13059-019-1629-z
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Kirsch R, Koutrouli M, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638–D646.
   PubMed Web of Science ®Google Scholar
• Li Z, Liu Y, Fang X, et al. Nanomaterials enhance the immunomodulatory effect of molecular targeted therapy. Int J Nanomedicine. 2021;16:1631–1661. doi: 10.2147/IJN.S290346
   PubMed Web of Science ®Google Scholar
• Zhong L, Li Y, Xiong L, et al. Small molecules in targeted cancer therapy: advances, challenges, and future perspectives. Signal Transduct Target Ther. 2021;6(1):201. doi: 10.1038/s41392-021-00572-w
   PubMed Web of Science ®Google Scholar
• Yang D, Chen M, Sun Y, et al. Microneedle-mediated transdermal drug delivery for treating diverse skin diseases. Acta Biomater. 2021;121:119–133. doi: 10.1016/j.actbio.2020.12.004
   PubMed Web of Science ®Google Scholar
• Honma M, Hayashi K. Psoriasis: recent progress in molecular‐targeted therapies. J Dermatol. 2021;48(6):761–777. doi: 10.1111/1346-8138.15727
   PubMed Web of Science ®Google Scholar
• Guo J, Zhang H, Lin W, et al. Signaling pathways and targeted therapies for psoriasis. Signal Transduct Target Ther. 2023;8(1):437. doi: 10.1038/s41392-023-01655-6
   PubMed Web of Science ®Google Scholar
• Tokuyama M, Mabuchi T. New treatment addressing the pathogenesis of psoriasis. Int J Mol Sci. 2020;21(20):7488. doi: 10.3390/ijms21207488
   PubMed Web of Science ®Google Scholar
• Gupta R. Prolonged remission of psoriasis with azathioprine pulse therapy. Indian J Dermatol. 2015;60(4):360–363. doi: 10.4103/0019-5154.160480
   PubMed Web of Science ®Google Scholar
• Bowcock AM. The genetics of psoriasis and autoimmunity. Annu Rev Genomics Hum Genet. 2005;6(1):93–122. doi: 10.1146/annurev.genom.6.080604.162324
   PubMedGoogle Scholar
• Ran D, Cai M, Zhang X. Genetics of psoriasis: a basis for precision medicine. Precis Clin Med. 2019;2(2):120–130. doi: 10.1093/pcmedi/pbz011
   PubMedGoogle Scholar
• Gunter NV, Yap BJM, Chua CLL, et al. Combining understanding of immunological mechanisms and genetic variants toward development of personalized medicine for psoriasis patients. Front Genet. 2019;10:395. doi: 10.3389/fgene.2019.00395
   PubMed Web of Science ®Google Scholar
• Vide J, Magina S. Moderate to severe psoriasis treatment challenges through the era of biological drugs. An Bras Dermatol. 2017;92(5):668–674. doi: 10.1590/abd1806-4841.20175603
   PubMed Web of Science ®Google Scholar
• Piragine E, Petri D, Martelli A, et al. Adherence and persistence to biological drugs for psoriasis: systematic review with meta-analysis. J Clin Med. 2022;11(6):1506. doi: 10.3390/jcm11061506
   PubMed Web of Science ®Google Scholar
• Ożóg MK, Grabarek BO, Wierzbik-Strońska M, et al. Neurological complications of biological treatment of psoriasis. Life Basel Switz. 2022;12(1):118. doi: 10.3390/life12010118
   PubMed Web of Science ®Google Scholar
• Niu L, Fang Y, Yao X, et al. TNFα activates MAPK and jak-stat pathways to promote mouse müller cell proliferation. Exp Eye Res. 2021;202:108353. doi: 10.1016/j.exer.2020.108353
   PubMed Web of Science ®Google Scholar
• Li Q, Cheng F, Zhou K, et al. Increased sensitivity to TNF‑α promotes keloid fibroblast hyperproliferation by activating the NF‑κB, JNK and p38 MAPK pathways. Exp Ther Med. 2021;21(5):502. doi: 10.3892/etm.2021.9933
   PubMed Web of Science ®Google Scholar
• Asl ER, Amini M, Najafi S, et al. Interplay between MAPK/ERK signaling pathway and MicroRNAs: a crucial mechanism regulating cancer cell metabolism and tumor progression. Life Sci. 2021;278:119499. doi: 10.1016/j.lfs.2021.119499
   PubMed Web of Science ®Google Scholar
• Krawczyk A, Strzałka-Mrozik B, Grabarek B, et al. mRNA level of ROCK1, RHOA, and LIMK2 as genes associated with apoptosis in evaluation of effectiveness of adalimumab treatment. Pharmacol Rep PR. 2020;72(2):389–399. doi: 10.1007/s43440-020-00068-4
   PubMed Web of Science ®Google Scholar
• Kjellerup RB, Johansen C, Kragballe K, et al. The expression of dual-specificity phosphatase 1 mRNA is downregulated in lesional psoriatic skin. Br J Dermatol. 2013;168(2):339–345. doi: 10.1111/bjd.12020
   PubMed Web of Science ®Google Scholar
• Tan Y, Qi Q, Lu C, et al. Cytokine imbalance as a common mechanism in both psoriasis and rheumatoid arthritis. Mediators Inflamm. 2017;2017:2405291. doi: 10.1155/2017/2405291
   PubMed Web of Science ®Google Scholar
• Seternes OM, Kidger AM, Keyse SM. Dual-specificity MAP kinase phosphatases in health and disease. Biochim Biophys Acta Mol Cell Res. 2019;1866(1):124–143. doi: 10.1016/j.bbamcr.2018.09.002
   PubMed Web of Science ®Google Scholar
• Zhao W, Xiao S, Li H, et al. MAPK phosphatase-1 deficiency exacerbates the severity of imiquimod-induced psoriasiform skin disease. Front Immunol. 2018;9:569. doi: 10.3389/fimmu.2018.00569
   PubMed Web of Science ®Google Scholar
• Pulido R, Lang R. Dual specificity phosphatases: from molecular mechanisms to biological function. Int J Mol Sci. 2019;20(18):4372. doi: 10.3390/ijms20184372
   PubMed Web of Science ®Google Scholar
• Sun F, Yue TT, Yang CL, et al. The MAPK Dual Specific Phosphatase (DUSP) Proteins: a versatile wrestler in T cell functionality. Int Immunopharmacol. 2021;98:107906. doi: 10.1016/j.intimp.2021.107906
   PubMed Web of Science ®Google Scholar
• Subbannayya Y, Pinto SM, Bösl K, et al. Dynamics of dual specificity phosphatases and their interplay with protein kinases in immune signaling. Int J Mol Sci. 2019;20(9):2086. doi: 10.3390/ijms20092086
   PubMed Web of Science ®Google Scholar
• Zhang Y, Reynolds JM, Chang SH, et al. MKP-1 is necessary for T cell activation and function. J Biol Chem. 2009;284(45):30815–30824. doi: 10.1074/jbc.M109.052472
   PubMed Web of Science ®Google Scholar
• Valinezhad Orang A, Safaralizadeh R, Kazemzadeh-Bavili M. Mechanisms of miRNA-Mediated Gene Regulation from Common Downregulation to mRNA-specific upregulation. Int J Genomic. 2014;2014:e970607. doi: 10.1155/2014/970607
   PubMed Web of Science ®Google Scholar
• Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRnas. Annu Rev Biochem. 2010;79(1):351–379. doi: 10.1146/annurev-biochem-060308-103103
   PubMed Web of Science ®Google Scholar
• Yao Q, Chen Y, Zhou X. The roles of microRnas in epigenetic regulation. Curr Opin Chem Biol. 2019;51:11–17. doi: 10.1016/j.cbpa.2019.01.024
   PubMed Web of Science ®Google Scholar
• Najar M, Fayyad-Kazan H, Faour WH, et al. Immunological modulation following bone marrow-derived mesenchymal stromal cells and Th17 lymphocyte co-cultures. Inflamm Res. 2019;68(3):203–213. doi: 10.1007/s00011-018-1205-0
   PubMed Web of Science ®Google Scholar
• Delmas D, Limagne E, Ghiringhelli F, et al. Immune Th17 lymphocytes play a critical role in the multiple beneficial properties of resveratrol. Food Chem Toxicol. 2020;137:111091. doi: 10.1016/j.fct.2019.111091
   PubMed Web of Science ®Google Scholar
• Chen H, Xiong Y, Liu L, et al. MicroRNA-34a inhibits proliferation and stimulates apoptosis in human keratinocyte through activation of smac-mediated mitochondrial apoptotic pathway: a potential therapeutic target for psoriasis. Int J Clin Exp Pathol 2017;10(1):266–273.
   Web of Science ®Google Scholar
• Wang H, Zhang X, Bu J, et al. Regulation of Notch1 and Foxp1 by MiR-34a in psoriasis vulgaris. Int J Morphol. 2022;40(3):735–741. doi: 10.4067/S0717-95022022000300735
   Web of Science ®Google Scholar
• Gang L, Qun L, Liu WD, et al. MicroRNA-34a promotes cell cycle arrest and apoptosis and suppresses cell adhesion by targeting DUSP1 in osteosarcoma. Am J Transl Res. 2017;9(12):5388–5399. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752889/
   PubMed Web of Science ®Google Scholar
• Li Y, Shao J, Song J, et al. MiR-34a-3p suppresses pulmonary vascular proliferation in acute pulmonary embolism rat by targeting DUSP1. Biosci Rep. 2022;42(1):BSR20210116. doi: 10.1042/BSR20210116
   PubMed Web of Science ®Google Scholar
• Zaba LC, Suárez- Fariñfariñas M, Fuentes-Duculan J, et al. Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes. J Allergy Clin Immunol. 2009;124(5):1022–1030.e395. doi: 10.1016/j.jaci.2009.08.046
   PubMed Web of Science ®Google Scholar
• Mrowka R. Recent advances in kidney research. Acta Physiol. 2022;235(2):e13820. doi: 10.1111/apha.13820
   PubMed Web of Science ®Google Scholar
• Loh CY, Arya A, Naema AF, et al. Signal Transducer and Activator of Transcription (STATs) proteins in cancer and inflammation: functions and therapeutic implication. Front Oncol. 2019;9:48. doi: 10.3389/fonc.2019.00048
   PubMed Web of Science ®Google Scholar
• Huang CY, Lin YC, Hsiao WY, et al. DUSP4 deficiency enhances CD25 expression and CD4+ T-cell proliferation without impeding T-cell development. Eur J Immunol. 2012;42(2):476–488. doi: 10.1002/eji.201041295
   PubMed Web of Science ®Google Scholar
• Hsiao WY, Lin YC, Liao FH, et al. Dual-specificity phosphatase 4 regulates STAT5 protein stability and helper T cell polarization*. PLoS One. 2015;10(12):e0145880. doi: 10.1371/journal.pone.0145880
   PubMed Web of Science ®Google Scholar
• Johar AS, Mastronardi C, Rojas-Villarraga A, et al. Novel and rare functional genomic variants in multiple autoimmune syndrome and sjögren’s syndrome. J Transl Med. 2015;13(1):173. doi: 10.1186/s12967-015-0525-x
   PubMedGoogle Scholar
• Dougherty JA, Kilbane Myers J, Khan M, et al. Dual-specificity phosphatase 4 overexpression in cells prevents Hypoxia/Reoxygenation-induced apoptosis via the upregulation of eNOS. Front Cardiovasc Med. 2017;4. [cited 2023 December 22] doi: 10.3389/fcvm.2017.00022
   PubMed Web of Science ®Google Scholar
• Li Z, Chen B. DUSP4 alleviates LPS-induced chondrocyte injury in knee osteoarthritis via the MAPK signaling pathway. Exp Ther Med. 2021;22(6):1401. doi: 10.3892/etm.2021.10837
   PubMed Web of Science ®Google Scholar
• Li N, Chen J, Zhao J, et al. MicroRNA-3188 targets ETS-domain protein 4 and participates in RhoA/ROCK pathway to regulate the development of atherosclerosis. Pharm. 2017;72(11):687–693. doi: 10.1691/ph.2017.7686
   Google Scholar
• Zhou Q, Hu Z, Ye P, et al. Differential microRNA profiles between fulvestrant-resistant and tamoxifen-resistant human breast cancer cells - PubMed. Anticancer Drugs. 2018;29(6):539–548. doi: 10.1097/CAD.0000000000000623
   PubMed Web of Science ®Google Scholar
• Zhao M, Luo R, Liu Y, et al. Author correction: miR-3188 regulates nasopharyngeal carcinoma proliferation and chemosensitivity through a FOXO1-modulated positive feedback loop with mTOR-p-PI3K/AKT-c-JUN. Nat Commun. 2021;12(1):2997.
   PubMed Web of Science ®Google Scholar
• Mie Y, Hirano Y, Kowata K, et al. Function control of anti-microRNA oligonucleotides using interstrand cross-linked duplexes. Mol Ther Nucleic Acid. 2017;10:64–74. doi: 10.1016/j.omtn.2017.11.003
   PubMedGoogle Scholar
• Grabarek B, Schweizer P, Adwent I, et al. Differences in expression of genes related to drug resistance and miRNAs regulating their expression in skin fibroblasts exposed to adalimumab and cyclosporine a. Adv Dermatol Allergol Dermatol Alergol. 2020;38(2):249–255.
   PubMed Web of Science ®Google Scholar
• Grabarek B, Wcislo-Dziadecka D, Gola J, et al. Changes in the expression profile of JAK/STAT signaling pathway genes and miRNAs regulating their expression under the adalimumab therapy. Curr Pharm Biotechnol. 2018;19(7):556–565. doi: 10.2174/1389201019666180730094046
   PubMed Web of Science ®Google Scholar
• Grabarek BO, Wcisło-Dziadecka D, Michalska-Bańkowska A, et al. Evaluation of expression pattern of selected genes associated with IL12/23 signaling paths in psoriatic patients during cyclosporine a therapy. Dermatol Ther. 2019;32(6):e13129. doi: 10.1111/dth.13129
   PubMed Web of Science ®Google Scholar
• Grabarek B, Wcisło-Dziadecka D, Strzałka-Mrozik B, et al. The capability to forecast response to therapy with regard to the time and intensity of the inflammatory process in vitro in dermal fibroblasts induced by IL-12. Curr Pharm Biotechnol. 2018;19(15):1232–1240. doi: 10.2174/1389201020666190111163312
   PubMed Web of Science ®Google Scholar
• Denninger K, Rasmussen S, Larsen JM, et al. JNK1, but not JNK2, is required in two mechanistically distinct models of inflammatory arthritis. Am J Pathol. 2011;179(4):1884–1893. doi: 10.1016/j.ajpath.2011.06.019
   PubMed Web of Science ®Google Scholar
• Bertelsen T, Ljungberg C, Litman T, et al. IκBζ is a key player in the antipsoriatic effects of secukinumab. J Allergy Clin Immunol. 2020;145(1):379–390. doi: 10.1016/j.jaci.2019.09.029
   PubMed Web of Science ®Google Scholar
• Yang J, Do-Umehara HC, Zhang Q, et al. miR-221-5p-mediated downregulation of JNK2 aggravates acute lung injury. Front Immunol. 2021;12. [cited 2023 December 22] doi: 10.3389/fimmu.2021.700933
   Web of Science ®Google Scholar
• Chong ZX, Yeap SK, Ho WY, et al. Unveiling the tumour-regulatory roles of miR-1275 in cancer. Pathol Res Pract. 2022;230:153745. doi: 10.1016/j.prp.2021.153745
   PubMedGoogle Scholar
• Huang L, Guo B, Yan J, et al. CircHSPG2 knockdown attenuates hypoxia-induced apoptosis, inflammation, and oxidative stress in human AC16 cardiomyocytes by regulating the miR-1184/MAP3K2 axis. Cell Stress Chaperones. 2023;28(2):177–190. doi: 10.1007/s12192-023-01328-x
   PubMed Web of Science ®Google Scholar
• Magenta A, D’Agostino M, Sileno S, et al. The oxidative stress-induced miR-200c is upregulated in psoriasis and correlates with disease severity and determinants of cardiovascular risk. Oxid Med Cell Longev. 2019;2019:8061901. doi: 10.1155/2019/8061901
   PubMed Web of Science ®Google Scholar
• Mavropoulos A, Rigopoulou EI, Liaskos C, et al. The role of p38 MAPK in the aetiopathogenesis of psoriasis and psoriatic arthritis. Clin Dev Immunol. 2013;2013:569751. doi: 10.1155/2013/569751
   PubMedGoogle Scholar
• Fiore M, Forli S, Manetti F. Targeting mitogen-activated protein kinase-activated protein kinase 2 (MAPKAPK2, MK2): medicinal chemistry efforts to lead small molecule inhibitors to clinical trials. J Med Chem. 2016;59(8):3609–3634. doi: 10.1021/acs.jmedchem.5b01457
   PubMed Web of Science ®Google Scholar
• Kumar S, Principe DR, Singh SK, et al. Mitogen-activated protein kinase inhibitors and T-cell-dependent immunotherapy in cancer. Pharm. 2020;13(1):9. doi: 10.3390/ph13010009
   Google Scholar
• Zhong QH, Lau AT, Xu YM. Mitogen-activated protein kinase 15 is a new predictive biomarker and potential therapeutic target for ovarian cancer. Int J Mol Sci. 2023;25(1):109. doi: 10.3390/ijms25010109
   PubMed Web of Science ®Google Scholar
• Han J, Wu J, Silke J. An overview of mammalian p38 mitogen-activated protein kinases, central regulators of cell stress and receptor signaling. F1000Research. 2020;9:653. doi: 10.12688/f1000research.22092.1
   Google Scholar
• Ray, Ray AL, Berggren KL, et al. Inhibition of MK2 suppresses IL‐1β, IL‐6, and TNF‐α‐dependent colorectal cancer growth. 2018. Wiley Online Library Int J Cancer. 142(8):1702–1711. [cited 2024 February 4]. 10.1002/ijc.31191.
   PubMed Web of Science ®Google Scholar
• Krawczyk A, Strzałka-Mrozik B, Juszczyk K, et al. The MAP2K2 gene as potential diagnostic marker in monitoring adalimumab therapy of psoriatic arthritis. doi: 10.2174/1389201023666220628111644
   Google Scholar